1. World Health Organization. World Health Statistics. 2014.

2. Benenson. Control of Communicable Diseases Manual. 16th ed. Washington

D.C: American Public Health Association; 1995.
3. Girard, Perraud, Prss, Savey, Tikhomirov. Prevention of hospital-acquired
infections, A practical guide. 2nd ed. 2002.
4. Saha JC. Nosocomial Infections As A Preventable Burden for health Care
Delivery. Faridpur Medical College Journal. 2010 Jan 1;5.
5. Wesetian, 2006. Kewaspadaan Nosokomial, Yayasan Spritia, [diakses pada
tanggal 27Februari 2015]. Available from: http:///Spritia. or.id/est/dok/kol.pdf
6. Potter, Patricia A., & Anne Griffin Perry. Buku Ajar Fundamental Keperawatan:
Konsep, Proses dan Praktik. Edisi 4. Vol, 2. Jakarta: EGC. 2005
7. Tietjen, Linda dkk. Panduan Pencegahan Infeksi Untuk Fasilitas Pelayanan
Kesehatan dengan Sumber Daya Terbatas. Yayasan Bina Pustaka Sarwono
Prawiroharjo, Jakarta. 2004
8. Ducel G, Fabry J : Prevention of Hospital Aquired Infections a Practical guide,
World Health Organisation. 2002
9. Vincent,J.L .Nosocomial Infections In Adult Intensive Care Units, The Lancet,
Volume 361, pp 2068-2077. 2003
10. Gadi Borkow, and Alastair Monk. Fighting nosocomial infections with biocidal
non-intrusive hard and soft surfaces. World J Clin Infect Dis 2012 August 25;
2(4): 77-90
11. Victor,D., Dennis, G.M., Ajita, M., Carlos, A. M., Hakan, L.,Francisco, H.,
Luis,E.C., Naoufel, M., Zan,M., Lourdes,D., Josephine,A.N., Humberto, G.G., Lul,
R., Rosala, F.H., Eduardo, A.M., Souha, S.K., Salisu, A., and Patricio, N. 2008.
International Nosocomial Infection Control Consortium report, data summery for
2002- 2007, American Journal of Infection Control.

12. Bratzler DW, Dellinger EP, Olsen KM, Peri TM, Auwaerter PG, Bolon MK. Clinical
Practice Guidelines for Antimicrobial Prophylaxis in Surgery. Am J Health-Syst
Pharm. 2013. p. 205.
13. World Health Organization. Prevention of Hospital Acquired Infections. A Practical
Guide. 2nd ed. Department of Communicable Disease, Surveilance and Report.
2002.
14. Centers for Disease Control and Prevention. Antibiotic resistance threats in The
United States. 2013.
15. McCance KL, Huether SE. Pathophysiology, 6 th Edition. The Biologic Basis for
Disease in Adults and Children. Mosby, 2014.
16. Departemen Kesehatan RI. Pedoman Penyelenggaraan PONEK 24 Jam di
Rumah Sakit. Jakarta. 2012
17. WHO.Prevention of Hospital Acquired Infection, A Practical Guide, 2nd Edition.
2004
18. Ahmed. Haddadi, Mohamed Lemdani, dan Hervet Hubert. Incidence, Dependent
And Independent Risk Factors Associated To Nosocomial Infections And To The
Mortality At The Intensive Care Unit Of The Timone University.2013
19. Centers For Disease Control and Prevention (CDC). Guideline For Hand Hygiene
in Health-Care Settings : Recommendations of the Health Care Infection Control
Practices Advisory Committee and the Hicpac/Shea/Apic/Idsa Hand Task Force.
Morbidity and Mortality Weekly Report, 51 (RR16).2002
20. Kementrian Kesahatan RI, 2012. Pedoman Teknis Bangunan Rumah Sakit
Ruang Operasi, Jakarta.
21. Departemen Kesehatan RI, 1995. Persyaratan Kesehatan Lingkungan Rumah
Sakit, Jakarta.
22. Jawetz E, Melnick J.L,

Adelberg E. A.. Review of medical microbiology.

Thirteenth edition. 260 185 mm. Pp. 550 + xiv. Illustrated. 1978. Los Altos, Ca:
Lange.
23. Soemarno, 2000. isolasi bactretri klinik, AAK Yogjakarta

24. Sukidjo, 2002. Metodologi Penelitian Kesehatan, Reneka Cipta, Jakarta

25. Holt GJ, Krieg RN, Sneath HAP, Staley HAP,Williams TS. Enterobacteriaceae. In:
Bergeysmanual of determinative bacteriology. International Edition. 9th ed.
Maryland: Williams& Wilkins; 1994. p. 179-80.
26. Brooks GF, Butel SJ, Morse AS.Medical microbiology. International Edition. 22nd
ed. New York: McGraw-Hill Co; 2001
27. Lindgren P K, Karlsson A, Hughes D. Mutation rate and evolution of
fluoroquinolone resistance in Escherichia coli isolates from patients with urinary
tract infections. Antimicrob Agents Chemother. 2003; 47: 3222-32.
28. Mauren, K., et al. The Magnitude of the Association between Fluoroquinolone
Use and Quinolone-Resistant Escherichia coli and Klebsiella pneumoniae May
Be Lower than Previously Reported.2003
29. Nilsson AI, Berg OG, Aspeval O, Kahlmeter G,Andersson DI. Biological costs and
mechanisms of fosfomycin resistance in Escherichia coli . Antimicrob Agents
Chemother 2003; 47: 2850-8
30. Stephan Harbarth and Matthew

H.

Determinants and Future Control. 2005

31. Madigan
M.T.,J.K. Martinko,
and

Samore.
J.

Antimicrobial

Parker. Book

Resistance.
Biology

of

Microorganisms.5th Edition. USA: Pearson Education, p. 370, 633-637, 673, 745.

2003
32. Jrgen Schrezenmeir and Michael de Vrese. Probiotics, prebiotics, and
synbioticsapproaching a definition. Am J Clin Nutr. 2001
33. Todar K. Textbook of Bacteriology : Pseudomonas aeruginosa. USA:University of
Wisconsin-Madison Department of Bacteriology. 2004
34. Levinson, W and E. Jawetz . Medical Microbiology

&

Imunology

Examination & Board Review. 7th Edition.USA: McGraw-Hill Company. Hal

130-131. 2003

35. Foca, M., et al. 2000. Endemic Pseudomonas in neonatal Intensive Care Unit. N
Engl.J. Med.
36. Niels. Recent advances in the treatment of Pseudomonas aeruginosa infections
in cystic fibrosis. Hiby BMC Medicine 2011, 9:32
37. Franklin D. Lowy. Staphylococcus Aureus Infections.The New England Journal of
Medicine. 1998
38. Brooks GF, Butel JS, and Morse SA. Mikrobiologi Kedokteran Jawetz,
Melnick, dan Adelberg, ed. 20. Edi Nugroho (alih bahasa), 1996, Penerbit Buku
Kedokteran EGC, Jakarta, Indonesia.1995
39. Leticia I. Llarrull, Jed F. Fisher, and Shahriar Mobashery. Molecular Basis and
Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into
New Lactams That Meet the Challenge.2009
40. Harris
LG,
Foster
SJ,
Richard
RG.

An

introduction

to

Staphylococcusaureus and Techniques for Identifying and QuantifyingS. Aureus

Adhesins in Relation to Adhesion to Biomaterials: Review. European Cells and
Materials; 2002; 4: 39-21.
41. Setiabudy R. Antimikroba. Dalam: Gunawan SG. Farmakologi dan Terapi. Ed 5.
Jakarta: Balai Penerbit FK UI, 2009: 585
42. Mutschler E. Dinamika obat. Ed 5. Alih Bahasa. Widianto MB, Ranti AS Bandung:
Penerbit ITB, 1991: 608-56.
43. Katzung BG. Farmakologi dasar dan klinik. Ed 6. Alih bahasa. Staf Dosen
Farmakologi FK Universitas Sriwijaya. Jakarta: EGC, 1995: 699-705.
44. WHO Department of Communicable Disease Surveillance and Response. WHO
global strategy for containment of antimicrobial resistance. WHO Web site. [On
Line]:URL. http://www.who.int/emc.
45. Gold HS, Mollering RC. Antimicrobioal drug resistance. N Engl J Med
1996;335:44553.
46. Cassir N, Rolain J-M, Brouqui P. A new strategy to fight antimicrobial resistance:
the revival of old antibiotics. Frontiers in Microbiology. 2014 Oct 20;5(551).

47. World

Health

Organization.

Antimicrobial

resistance,

global

report

on

surveillance. 2014.
48. Mieke Hemiawati Satari. Multidrugs Resistance (MDR) Bakteri Terhadap
Antibiotik.
49. Prescott LM,Harley JP,Klein DA. Microbiology 5thed. Mc Graw Hill Asia
Ed,2003.p805-25.
50. Pedro Arde,Joana Ministro,Duarte C. Oliveira Redefining the Role of theLactamase Locus in Methicillin-Resistant Staphylococcus aureus:-Lactamase
Regulators Disrupt the MecI-Mediated Strong Repression on mecA and Optimize
the Phenotypic Expression of Resistance in Strains with Constitutive mecA
Expression.2013
51. Patel GP, Crank CW. Antimicrobial resistance in gram-positive and gramnegative bacteria. Mackinnon KJ, Swanson LS, editors. Inet Continuing
Education. 2005.
52.